Pharmaceutical ProcessingCellectis Granted Patent for CRISPR Use in T-CellsPharmaceutical ProcessingEP3004337 for the invention of using RNA-guided endonucleases, such as Cas9 or Cpf1, for the genetic engineering of T-cells. The patent will be issued o… Continue reading
Editas Medicine, Inc. (NASDAQ:EDIT) Experiences Lighter than Average Trading VolumeHighlight PressCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevo… Continue reading
Editas Medicine, Inc. (NASDAQ:EDIT) Experiences Lighter than Average Trading VolumeHighlight PressCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevo… Continue reading
The Columbus Dispatch |
Patients’ plasma, stem cells help knee problems
The Columbus Dispatch Dennis Matko was headed for a knee replacement when he discovered a new therapy that would instead inject his own stem cells and plasma into the joint to help prevent degradation. The 69-year-old Clintonville resident said he had been pretty active in … |
LifeZette |
Stem Cell Revelation: It’s Unproven for Heart Failure
LifeZette Stem cell therapy isn’t approved to treat heart failure in the U.S., but dozens of clinics nationwide advertise the treatments anyway, often charging thousands of dollars for procedures that may not be safe or effective, a new study suggests … |